1-100158232-T-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_144620.4(LRRC39):c.512A>C(p.Glu171Ala) variant causes a missense, splice region change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Consequence
LRRC39
NM_144620.4 missense, splice_region
NM_144620.4 missense, splice_region
Scores
1
6
12
Splicing: ADA: 0.9992
2
Clinical Significance
Conservation
PhyloP100: 6.75
Genes affected
LRRC39 (HGNC:28228): (leucine rich repeat containing 39) Predicted to enable protein serine/threonine phosphatase activity. Predicted to be involved in signal transduction. Predicted to be located in M band. Predicted to be active in cytoplasm and intracellular membrane-bounded organelle. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRC39 | NM_144620.4 | c.512A>C | p.Glu171Ala | missense_variant, splice_region_variant | 6/10 | ENST00000370137.6 | NP_653221.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRC39 | ENST00000370137.6 | c.512A>C | p.Glu171Ala | missense_variant, splice_region_variant | 6/10 | 1 | NM_144620.4 | ENSP00000359156 | P1 | |
LRRC39 | ENST00000370138.1 | c.512A>C | p.Glu171Ala | missense_variant, splice_region_variant | 6/11 | 5 | ENSP00000359157 | |||
LRRC39 | ENST00000342895.8 | c.512A>C | p.Glu171Ala | missense_variant, splice_region_variant | 6/10 | 5 | ENSP00000344470 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 30
GnomAD4 exome
Cov.:
30
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 31, 2023 | The c.512A>C (p.E171A) alteration is located in exon 6 (coding exon 4) of the LRRC39 gene. This alteration results from a A to C substitution at nucleotide position 512, causing the glutamic acid (E) at amino acid position 171 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;.;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
M;M;M;M
MutationTaster
Benign
D;D;D
PrimateAI
Benign
T
PROVEAN
Uncertain
.;D;D;D
REVEL
Benign
Sift
Uncertain
.;D;D;D
Sift4G
Benign
T;T;T;T
Polyphen
P;P;P;P
Vest4
MutPred
Gain of catalytic residue at E171 (P = 0.1411);Gain of catalytic residue at E171 (P = 0.1411);Gain of catalytic residue at E171 (P = 0.1411);Gain of catalytic residue at E171 (P = 0.1411);
MVP
MPC
0.13
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.